Premium
Body mass index does not impact on molecular response rate of chronic myeloid leukaemia patients treated frontline with second generation tyrosine kinase inhibitors
Author(s) -
Molica Matteo,
Canichella Martina,
Colafigli Gioia,
Latagliata Roberto,
Diverio Daniela,
Alimena Giuliana,
Foà Robin,
Breccia Massimo
Publication year - 2018
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/bjh.14783
Subject(s) - chronic myeloid leukaemia , tyrosine kinase , medicine , body mass index , tyrosine kinase inhibitor , myeloid leukaemia , tyrosine , oncology , cancer research , immunology , biology , cancer , receptor , biochemistry
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom